Antimicrobial Therapy Interruption

Antimicrobial Therapy Interruption is a clinical practice involving the deliberate and premature discontinuation of prescribed antimicrobial agents during an ongoing treatment course, distinguished from regimen completion or dose adjustment by its intentional suspension prior to therapeutic conclusion for reasons such as toxicity mitigation, lack of efficacy, or stewardship-driven reassessment.

39

Publications

3.8K

Citations

301

Authors

167

Institutions

Publications per year

2017–2026

5

Authors

301

  1. SG
    Steven G. Deeks

    University of California, San Francisco, United States

    2 publications · 234 citations

    2

    h-index

  2. ER
    Eric Rosenberg

    Massachusetts General Hospital, United States

    2 publications · 85 citations

    2

    h-index

  3. BM
    Brian M. Adams

    North Carolina State University, United States

    2 publications · 85 citations

    2

    h-index

  4. JA
    Jintanat Ananworanich

    HIV Netherlands Australia Thailand Research Collaboration, Thailand

    2 publications · 446 citations

    2

    h-index

  5. DR
    Darren R. Linkin

    University of Pennsylvania, United States

    2 publications · 79 citations

    2

    h-index

1–5 of 301

Venues

  1. Journal of Clinical Microbiology

    JCM · 3 publications · 77 citations

    3

    h-index

  2. Critical Care Medicine

    2 publications · 626 citations

    2

    h-index

  3. CHEST Journal

    2 publications · 1.3K citations

    2

    h-index

  4. Infection Control and Hospital Epidemiology

    ICHE · 2 publications · 79 citations

    2

    h-index

  5. Antimicrobial Agents and Chemotherapy

    AAC · 2 publications · 128 citations

    2

    h-index

1–5